A national strategy for the elimination of hepatitis B and C phase two report
"Hepatitis B and C cause most cases of hepatitis in the United States and the world. The two diseases account for about a million deaths a year and 78 percent of world's hepatocellular carcinoma and more than half of all fatal cirrhosis. In 2013 viral hepatitis, of which hepatitis B virus...
Autores Corporativos: | , , , |
---|---|
Otros Autores: | , |
Formato: | Libro electrónico |
Idioma: | Inglés |
Publicado: |
Washington, District of Columbia :
The National Academies Press
2017.
|
Materias: | |
Ver en Biblioteca Universitat Ramon Llull: | https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009622092906719 |
Tabla de Contenidos:
- Introduction
- Targets for elimination
- Public health information
- Essential interventions
- Service delivery
- Financing elimination
- Research
- Appendix A: Population health impact and cost-effectiveness of chronic hepatitis B diagnosis, care, and treatment in the United States
- Appendix B: Modeling the elimination of hepatitis C in the United States
- Appendix C: Public meeting agenda
- Appendix D: Committee biographies.